By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Organogenesis Inc. 

150 Dan Road

Canton  Massachusetts  02021  U.S.A.
Phone: 781-575-0775 Fax: 781-575-0440


Key Statistics

Ownership: Private

Web Site: Organogenesis

Medical Device

Company News
Organogenesis Release: New Research Highlights Ability Of PuraPly And PuraPly Antimicrobial (AM) To Manage Bioburden And Support Healing Across Variety Of Wound Types 5/19/2016 6:33:14 AM
Organogenesis Release: Award-Winning Research From The University Of Miami Evaluates Apligraf's Role In Reversing A Chronic Wound Environment 5/11/2016 1:39:43 PM
Organogenesis Bags $30 Million to Fund Aggressive Expansion and Beef Up Salesforce 4/14/2016 9:59:12 AM
Organogenesis Inc.' Expanding Wound Care Portfolio Featured In Eight New Presentations This Week At SAWC/WHS Spring 2016 4/14/2016 8:55:02 AM
MiMedx Revives Organogenesis Inc. Beef 12/30/2015 9:14:13 AM
Organogenesis Inc. Release: Apligraf Wound Healing Technology Becomes First Transplant Product To Receive Marketing Approval In Switzerland 11/2/2015 10:39:19 AM
Organogenesis Inc. Release: Comparative Effectiveness Analyses Report Faster Healing Times, Improved Probability Of Chronic Wound Closure With Apligraf And Dermagraft 10/8/2015 9:47:42 AM
Organogenesis Inc. To Feature Comparative Effectiveness Analyses And New Products At SAWC Fall 2015 9/25/2015 11:31:08 AM
Organogenesis Inc. Launches New PuraPly Products At The APMA 2015 Annual Scientific Meeting 7/22/2015 12:02:29 PM
Organogenesis Inc. Release: Landmark New Data: Apligraf Closes Significantly More Diabetic Foot Ulcers In Half The Time When Compared To Epifix 6/22/2015 11:30:19 AM